Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05094999
Other study ID # 2020-A02583-36
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 20, 2021
Est. completion date September 20, 2024

Study information

Verified date September 2021
Source Assistance Publique - Hôpitaux de Paris
Contact Bernard VIGUE
Phone 0033145216310
Email bernard.vigue@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

"Severe traumatic brain injury (TBI) is a serious condition, common in young adults. It leads to sensorimotor and cognitive sequelae that hinder social reintegration. Neuronal plasticity must be used quickly before natural recovery impedes neuronal regrowth. In this respect, stopping sedation as soon as possible and early mobilization, even if the patients are unconscious, are recognized as useful measures to promote recovery. However, at the early stage, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest. By using the proprioceptive signatures of cyclic movements, proprioceptive stimulations can elicit the illusion of these movements. A motor response can even be obtained through the interactions between the peripheral nervous system and the central nervous system. Finally, such stimulations facilitate the initiation of the mimicked movements. Some studies have already shown the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases. The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote recovery in patients with severe traumatic brain injury. To test the hypothesis, the investigators conduct a randomized controlled trial on patients with severe traumatic brain injury. Every patient will be included as soon as possible in the ICU and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. The primary outcome measures will assess spasticity. The investigators also assess pain, coma recovery; muscle wasting and cognitive impairments. "


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 20, 2024
Est. primary completion date September 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Severe TBI : Glasgow coma score (GCS) = 8 (11) - Age = 18 years old - No pregnancy - Not being under guardianship - Be affiliated to the French social security system Exclusion Criteria: - Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury - Traumatic SCI

Study Design


Intervention

Device:
Proprioceptive stimulations
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Sham stimulations
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.

Locations

Country Name City State
France Bicêtre Hospital Le Kremlin-Bicêtre

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in the modified Ashworth scale (MAS) The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity) adductors and gracilis Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Primary Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS) The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Primary Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS) The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Primary Changes in the Spinal cord assessment tool for spastic reflexes (SCATS) This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Secondary Changes in the visual analog scale for the auto-assessment of problematic spasticity Score range from 0 to 100, higher values represent a higher degree of problematic spasticity. Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Secondary Changes in the visual analog scale for the auto-assessment of problematic spasticity Score range from 0 to 100, higher values represent a higher degree of problematic spasticity. Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Secondary Changes in the Coma recovery scale-revised (CRS-R) This measure enables to assess coma recovery (Score range from 0 to 23, higher values represent a better outcome) At inclusion, and at one month, 2 months and 1 year after the injury.
Secondary Changes in the Glasgow outcome scale (GOS) This measure enables to assess coma recovery (Score range from 0 to 5, higher values represent a better outcome) At inclusion, and at one month, 2 months and 1 year after the injury.
Secondary Changes in the Glasgow outcome scale-extended (GOS-E) This measure enables to assess coma recovery (Score range from 0 to 8, higher values represent a better outcome) At inclusion, and at one month, 2 months and 1 year after the injury.
Secondary Changes in the Disability rating scale (DRS) This measure enables to assess coma recovery (Score range from 0 to 29, lower values represent a better outcome) At inclusion, and at one month, 2 months and 1 year after the injury.
Secondary Changes in the quadriceps muscle thickness "Measured with ultrasound, average of two measures (at the border between the lower third and upper two-thirds between the anterior superior iliac spine and the upper pole of the patella, and at the midpoint between the anterior superior iliac spine and the upper pole of the patella) (Measure in centimeters, higher values represent a better outcome)" At inclusion, then once a week during the first month, and at 2 months, 6 months and 1 year after the injury
Secondary Changes in the Montreal cognitive assessment (MoCA) This measure enables to assess cognitive impairments (Score range from 0 to 30, higher values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the time to complete the bells cancellation test to assess cognitive impairments This measure enables to assess cognitive impairments (Measure in minutes and seconds, lower values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the digit span test to assess cognitive impairments This measure enables to assess cognitive impairments (Higher values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the Posttraumatic stress disorder checklist scale (PCLS) to assess cognitive impairments This measure enables to assess cognitive impairments (Score range from 17 to 85, lower values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the Hospital anxiety and depression scale (HAD scale) This measure enables to assess cognitive impairments (Score range from 0 to 42, lower values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
See also
  Status Clinical Trial Phase
Completed NCT00006447 - Supporting Traumatic Brain Injury (TBI) Caregivers Phase 2
Completed NCT02110290 - Effects of an Adapted Ski/Snowboarding Program on Quality of Life in Children With Physical Disabilities
Recruiting NCT05115929 - Standard Craniectomy Against Laparotomy for the Treatment of Traumatic Rise in Intracranial Pressure and the Effect on Long-term Outcome N/A
Completed NCT02215187 - Telehealth-Education-Based Program for Military Caregivers of Injured Service Members With Head Injuries N/A
Completed NCT02680210 - Self-defining Memories in Patients With a TBI N/A